Learn about these 5 key trends based on research featured in Cell Therapy and Gene Therapy Markets, 2021-2031 (published Feb. 2022), a recent report by Kalorama Information
Cell and gene therapy products are transforming the treatment of many acquired diseases such as cancer, diabetes, Parkinson’s disease and genetic diseases to correct defective genetic material. Additionally, cell and gene therapies are expanding into other areas of medicine including autoimmune diseases, cardiovascular diseases, musculoskeletal disease, dermatological diseases and many others.
In the new report Cell Therapy and Gene Therapy Markets, 2021-2031, Kalorama Information reveals that markets for cell therapy will continue to show strong growth with a forecast 29% compound annual growth rate (CAGR) between 2021 and 2031. The market for stem cells emerged more than a decade ago and now plays a large part in this market and will continue to be a major driver for growth. New therapies, including gene-modified cell therapies–CAR-T therapies–are the next generation of cell therapies that will capture a large and growing percentage of the market.
Gene therapies haven’t developed as rapidly as cell therapies, and early introductions were met with some resistance due to price. But there’s plenty of momentum in this segment as well. Today, pricing is being considered under various payment methods, including performance guarantees. Gene therapy markets are slower to develop and several therapies are one-time treatments thus limiting the revenue stream. Despite these challenges, gene therapies are expected to increase over the forecast period with a 19% CAGR.
Watch the one minute video below for more insights and important trends regarding the cell and gene therapy market. And as always, Kalorama Information offers even more by purchasing our reports.